Clinical potential of mechlorethamine gel for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma: a review on current efficacy and safety data
Kendall Liner,1 Celeste Brown,2 Laura Y McGirt3 1Division of Dermatology, Medical College of Georgia at Augusta Health, Augusta, GA, USA; 2School of Medicine, University of North Carolina at Chapel Hill, Carolinas Medical Center, Charlotte, NC, USA; 3Department of Hematology/Oncology, Levine Cancer...
Saved in:
Main Authors: | Liner K (Author), Brown C (Author), McGirt LY (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2018-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mechlorethamine gel usage in patients with mycosis fungoides in a lymphoma clinic
by: Robert Duffy, et al.
Published: (2020) -
Evaluation and management of patients with early-stage mycosis fungoides who interrupt or discontinue topical mechlorethamine gel because of dermatitis
by: Elaine S. Gilmore, MD, PhD, et al.
Published: (2020) -
Psoriasiform mycosis fungoides-cutaneous T-cell lymphoma in an African American
by: Austinn C. Miller, MD, et al.
Published: (2023) -
Polarization of Macrophages in Granulomatous Cutaneous T Cell Lymphoma Granulomatous Mycosis Fungoides Microenvironment
by: Lopez Dominguez Johanny, et al.
Published: (2022) -
Composite lymphoma: Mycosis fungoides with hodgkin′s lymphoma
by: Mehta Jalpa, et al.
Published: (2005)